The present invention discloses a method for the diagnosis of acute myeloid leukemia kit comprising: RT system and PCR amplification system; wherein said reverse system comprising: repeating T oligonucleotide OlogodT, reverse transcription reaction liquid, M-MLV reverse transcriptase, RNA inhibitors, ...
macrophage cell line model (in vitro) and acute lung injury mice model (in vivo). Furthermore, this study has involved various techniques to show the selective trapping of negatively charged pro-inflammatory cytokines (TNF-α and IL-6). In summary, modifications that confer AIPs the ability to...
Unique challenges to diagnosing sweet syndrome following induction chemotherapy for relapsed Acute Myeloid Leukemia (AML): A case and brief-review Sweet Syndrome (SS) is a rare inflammatory skin condition characterized by the sudden appearance of tender, erythematous or violaceous papules, plaques, an...
Diagnosing and Treating Chronic Lymphocytic Leukemia in 2009 Nilotinib Meets Primary Endpoint in Pivotal Trial Against Imatinib as First-Line Treatment in Chronic Myeloid Leukemia Patients Phase III Data Show Octreotide Reduced Risk of Disease Progression by 66% in Advanced Neuroendocrine Tumor Patients Paz...
Based on their previous discovery of progesterone-induced blocking factor (PIBF), European scientists have developed a diagnostic assay that could be used to detect pregnancy complications or cancer.
Methods of diagnosing acute myeloid leukemia using nucleic acids encoding FLT3 kinaseTo provide a nucleic acid encoding a receptor protein kinase, wherein the nucleic acid has tandem duplication in a nucleotide sequence of a juxtamembrane and is useful for diagnosis of leukemia; a polypeptide encoded...
The present invention relates to a method and kit for in vitro diagnosing a complex disease such as cancer, in particular, acute myeloid leukemia (AML), colon cancer, kidney cancer, prostate cancer; transient ischemic attack (TIA), ischemia, in particular stroke, hypoxia, hypoxic-ischemic ...
The present invention relates to a method for detecting c-Kit mutations by using a quantitative real-time PCR (qRT-PCR) method in order to diagnose acute myeloid leukemia and, more specifically, to a method for diagnosing acute myeloid leukemia, evaluating the prognosis thereof, and performing a...
The invention discloses an application of miR-125b in the diagnosis or treatment of acute myeloid leukemia. The invention applies the miR-125b to the early diagnosis of acute myeloid leukemia (AML) according to the nature that the expression level of the miR-125b in the marrow of an acute...
PURPOSE: A novel biomarker for acute myeloid leukemia is provided to diagnose acute myeloid leukemia and neutralize by specifically binding to biomarker.;CONSTITUTION: A biomarker for diagnosing acute myeloid leukemia contains TM6SF1(transmembrane 6 superfamily member 1) or TM7SF3(transmembrane 7 ...